Table of Contents 1 Dasatinib Drugs Market Overview 1.1 Product Overview and Scope of Dasatinib Drugs 1.2 Dasatinib Drugs Segment by Type 1.2.1 Global Dasatinib Drugs Sales Growth Rate Comparison by Type (2021-2026) 1.2.2 20mg 1.2.3 50mg 1.2.4 70mg 1.3 Dasatinib Drugs Segment by Application 1.3.1 Dasatinib Drugs Sales Comparison by Application: 2020 VS 2026 1.3.2 CML 1.3.3 ALL 1.4 Global Dasatinib Drugs Market Size Estimates and Forecasts 1.4.1 Global Dasatinib Drugs Revenue 2015-2026 1.4.2 Global Dasatinib Drugs Sales 2015-2026 1.4.3 Dasatinib Drugs Market Size by Region: 2020 Versus 2026 2 Global Dasatinib Drugs Market Competition by Manufacturers 2.1 Global Dasatinib Drugs Sales Market Share by Manufacturers (2015-2020) 2.2 Global Dasatinib Drugs Revenue Share by Manufacturers (2015-2020) 2.3 Global Dasatinib Drugs Average Price by Manufacturers (2015-2020) 2.4 Manufacturers Dasatinib Drugs Manufacturing Sites, Area Served, Product Type 2.5 Dasatinib Drugs Market Competitive Situation and Trends 2.5.1 Dasatinib Drugs Market Concentration Rate 2.5.2 Global Top 5 and Top 10 Players Market Share by Revenue 2.5.3 Market Share by Company Type (Tier 1, Tier 2 and Tier 3) 2.6 Manufacturers Mergers & Acquisitions, Expansion Plans 2.7 Primary Interviews with Key Dasatinib Drugs Players (Opinion Leaders) 3 Dasatinib Drugs Retrospective Market Scenario by Region 3.1 Global Dasatinib Drugs Retrospective Market Scenario in Sales by Region: 2015-2020 3.2 Global Dasatinib Drugs Retrospective Market Scenario in Revenue by Region: 2015-2020 3.3 North America Dasatinib Drugs Market Facts & Figures by Country 3.3.1 North America Dasatinib Drugs Sales by Country 3.3.2 North America Dasatinib Drugs Sales by Country 3.3.3 U.S. 3.3.4 Canada 3.4 Europe Dasatinib Drugs Market Facts & Figures by Country 3.4.1 Europe Dasatinib Drugs Sales by Country 3.4.2 Europe Dasatinib Drugs Sales by Country 3.4.3 Germany 3.4.4 France 3.4.5 U.K. 3.4.6 Italy 3.4.7 Russia 3.5 Asia Pacific Dasatinib Drugs Market Facts & Figures by Region 3.5.1 Asia Pacific Dasatinib Drugs Sales by Region 3.5.2 Asia Pacific Dasatinib Drugs Sales by Region 3.5.3 China 3.5.4 Japan 3.5.5 South Korea 3.5.6 India 3.5.7 Australia 3.5.8 Taiwan 3.5.9 Indonesia 3.5.10 Thailand 3.5.11 Malaysia 3.5.12 Philippines 3.5.13 Vietnam 3.6 Latin America Dasatinib Drugs Market Facts & Figures by Country 3.6.1 Latin America Dasatinib Drugs Sales by Country 3.6.2 Latin America Dasatinib Drugs Sales by Country 3.6.3 Mexico 3.6.3 Brazil 3.6.3 Argentina 3.7 Middle East and Africa Dasatinib Drugs Market Facts & Figures by Country 3.7.1 Middle East and Africa Dasatinib Drugs Sales by Country 3.7.2 Middle East and Africa Dasatinib Drugs Sales by Country 3.7.3 Turkey 3.7.4 Saudi Arabia 3.7.5 U.A.E 4 Global Dasatinib Drugs Historic Market Analysis by Type 4.1 Global Dasatinib Drugs Sales Market Share by Type (2015-2020) 4.2 Global Dasatinib Drugs Revenue Market Share by Type (2015-2020) 4.3 Global Dasatinib Drugs Price Market Share by Type (2015-2020) 4.4 Global Dasatinib Drugs Market Share by Price Tier (2015-2020): Low-End, Mid-Range and High-End 5 Global Dasatinib Drugs Historic Market Analysis by Application 5.1 Global Dasatinib Drugs Sales Market Share by Application (2015-2020) 5.2 Global Dasatinib Drugs Revenue Market Share by Application (2015-2020) 5.3 Global Dasatinib Drugs Price by Application (2015-2020) 6 Company Profiles and Key Figures in Dasatinib Drugs Business 6.1 Bristol-Myers Squibb 6.1.1 Corporation Information 6.1.2 Bristol-Myers Squibb Description, Business Overview and Total Revenue 6.1.3 Bristol-Myers Squibb Dasatinib Drugs Sales, Revenue and Gross Margin (2015-2020) 6.1.4 Bristol-Myers Squibb Products Offered 6.1.5 Bristol-Myers Squibb Recent Development 6.2 LUCIUS Pharma 6.2.1 LUCIUS Pharma Dasatinib Drugs Production Sites and Area Served 6.2.2 LUCIUS Pharma Description, Business Overview and Total Revenue 6.2.3 LUCIUS Pharma Dasatinib Drugs Sales, Revenue and Gross Margin (2015-2020) 6.2.4 LUCIUS Pharma Products Offered 6.2.5 LUCIUS Pharma Recent Development 7 Dasatinib Drugs Manufacturing Cost Analysis 7.1 Dasatinib Drugs Key Raw Materials Analysis 7.1.1 Key Raw Materials 7.1.2 Key Raw Materials Price Trend 7.1.3 Key Suppliers of Raw Materials 7.2 Proportion of Manufacturing Cost Structure 7.3 Manufacturing Process Analysis of Dasatinib Drugs 7.4 Dasatinib Drugs Industrial Chain Analysis 8 Marketing Channel, Distributors and Customers 8.1 Marketing Channel 8.2 Dasatinib Drugs Distributors List 8.3 Dasatinib Drugs Customers 9 Market Dynamics 9.1 Market Trends 9.2 Opportunities and Drivers 9.3 Challenges 9.4 Porter's Five Forces Analysis 10 Global Market Forecast 10.1 Global Dasatinib Drugs Market Estimates and Projections by Type 10.1.1 Global Forecasted Sales of Dasatinib Drugs by Type (2021-2026) 10.1.2 Global Forecasted Revenue of Dasatinib Drugs by Type (2021-2026) 10.2 Dasatinib Drugs Market Estimates and Projections by Application 10.2.1 Global Forecasted Sales of Dasatinib Drugs by Application (2021-2026) 10.2.2 Global Forecasted Revenue of Dasatinib Drugs by Application (2021-2026) 10.3 Dasatinib Drugs Market Estimates and Projections by Region 10.3.1 Global Forecasted Sales of Dasatinib Drugs by Region (2021-2026) 10.3.2 Global Forecasted Revenue of Dasatinib Drugs by Region (2021-2026) 10.4 North America Dasatinib Drugs Estimates and Projections (2021-2026) 10.5 Europe Dasatinib Drugs Estimates and Projections (2021-2026) 10.6 Asia Pacific Dasatinib Drugs Estimates and Projections (2021-2026) 10.7 Latin America Dasatinib Drugs Estimates and Projections (2021-2026) 10.8 Middle East and Africa Dasatinib Drugs Estimates and Projections (2021-2026) 11 Research Finding and Conclusion 12 Methodology and Data Source 12.1 Methodology/Research Approach 12.1.1 Research Programs/Design 12.1.2 Market Size Estimation 12.1.3 Market Breakdown and Data Triangulation 12.2 Data Source 12.2.1 Secondary Sources 12.2.2 Primary Sources 12.3 Author List 12.4 Disclaimer

List of Tables Table 1. Global Dasatinib Drugs Sales (K Units) Growth Rate Comparison by Type (2015-2026) Table 2. Global Dasatinib Drugs Sales (K Units) Comparison by Application: 2020 VS 2026 Table 3. Global Dasatinib Drugs Market Size by Type (K Units) (US$ Million) (2020 VS 2026) Table 4. Global Key Dasatinib Drugs Manufacturers Covered in This Study Table 5. Global Dasatinib Drugs Sales (K Units) by Manufacturers (2015-2020) Table 6. Global Dasatinib Drugs Sales Share by Manufacturers (2015-2020) Table 7. Global Dasatinib Drugs Revenue (Million USD) by Manufacturers (2015-2020) Table 8. Global Dasatinib Drugs Revenue Share by Manufacturers (2015-2020) Table 9. Global Market Dasatinib Drugs Average Price (USD/Unit) of Key Manufacturers (2015-2020) Table 10. Manufacturers Dasatinib Drugs Sales Sites and Area Served Table 11. Manufacturers Dasatinib Drugs Product Types Table 12. Global Dasatinib Drugs Manufacturers Market Concentration Ratio (CR5 and HHI) Table 13. Global Dasatinib Drugs by Company Type (Tier 1, Tier 2 and Tier 3) (based on the Revenue in Dasatinib Drugs as of 2019) Table 14. Manufacturers Mergers & Acquisitions, Expansion Plans Table 15. Main Points Interviewed from Key Dasatinib Drugs Players Table 16. Global Dasatinib Drugs Sales (K Units) by Region (2015-2020) Table 17. Global Dasatinib Drugs Sales Market Share by Region (2015-2020) Table 18. Global Dasatinib Drugs Revenue (Million US$) by Region (2015-2020) Table 19. Global Dasatinib Drugs Revenue Market Share by Region (2015-2020) Table 20. North America Dasatinib Drugs Sales by Country (2015-2020) (K Units) Table 21. North America Dasatinib Drugs Sales Market Share by Country (2015-2020) Table 22. North America Dasatinib Drugs Revenue by Country (2015-2020) (US$ Million) Table 23. North America Dasatinib Drugs Revenue Market Share by Country (2015-2020) Table 24. Europe Dasatinib Drugs Sales by Country (2015-2020) (K Units) Table 25. Europe Dasatinib Drugs Sales Market Share by Country (2015-2020) Table 26. Europe Dasatinib Drugs Revenue by Country (2015-2020) (US$ Million) Table 27. Europe Dasatinib Drugs Revenue Market Share by Country (2015-2020) Table 28. Asia Pacific Dasatinib Drugs Sales by Region (2015-2020) (K Units) Table 29. Asia Pacific Dasatinib Drugs Sales Market Share by Region (2015-2020) Table 30. Asia Pacific Dasatinib Drugs Revenue by Region (2015-2020) (US$ Million) Table 31. Asia Pacific Dasatinib Drugs Revenue Market Share by Region (2015-2020) Table 32. Latin America Dasatinib Drugs Sales by Country (2015-2020) (K Units) Table 33. Latin America Dasatinib Drugs Sales Market Share by Country (2015-2020) Table 34. Latin America Dasatinib Drugs Revenue by Country (2015-2020) (US$ Million) Table 35. Latin America Dasatinib Drugs Revenue Market Share by Country (2015-2020) Table 36. Middle East and Africa Dasatinib Drugs Sales by Country (2015-2020) (K Units) Table 37. Middle East and Africa Dasatinib Drugs Sales Market Share by Country (2015-2020) Table 38. Middle East and Africa Dasatinib Drugs Revenue by Country (2015-2020) (US$ Million) Table 39. Middle East and Africa Dasatinib Drugs Revenue Market Share by Country (2015-2020) Table 40. Global Dasatinib Drugs Sales (K Units) by Type (2015-2020) Table 41. Global Dasatinib Drugs Sales Share by Type (2015-2020) Table 42. Global Dasatinib Drugs Revenue (Million US$) by Type (2015-2020) Table 43. Global Dasatinib Drugs Revenue Share by Type (2015-2020) Table 44. Global Dasatinib Drugs Price (USD/Unit) by Type (2015-2020) Table 45. Global Dasatinib Drugs Sales (K Units) by Application (2015-2020) Table 46. Global Dasatinib Drugs Sales Market Share by Application (2015-2020) Table 47. Global Dasatinib Drugs Sales Growth Rate by Application (2015-2020) Table 48. Bristol-Myers Squibb Dasatinib Drugs Corporation Information Table 49. Bristol-Myers Squibb Description and Business Overview Table 50. Bristol-Myers Squibb Dasatinib Drugs Sales (K Units), Revenue (Million US$), Price (USD/Unit) and Gross Margin (2015-2020) Table 51. Bristol-Myers Squibb Main Product Table 52. Bristol-Myers Squibb Recent Development Table 53. LUCIUS Pharma Dasatinib Drugs Corporation Information Table 54. LUCIUS Pharma Corporation Information Table 55. LUCIUS Pharma Dasatinib Drugs Sales (K Units), Revenue (Million US$), Price (USD/Unit) and Gross Margin (2015-2020) Table 56. LUCIUS Pharma Main Product Table 57. LUCIUS Pharma Recent Development Table 58. Sales Base and Market Concentration Rate of Raw Material Table 59. Key Suppliers of Raw Materials Table 60. Dasatinib Drugs Distributors List Table 61. Dasatinib Drugs Customers List Table 62. Market Key Trends Table 63. Key Opportunities and Drivers: Impact Analysis (2021-2026) Table 64. Key Challenges Table 65. Global Dasatinib Drugs Sales (K Units) Forecast by Type (2021-2026) Table 66. Global Dasatinib Drugs Sales Market Share Forecast by Type (2021-2026) Table 67. Global Dasatinib Drugs Revenue (Million US$) Forecast by Type (2021-2026) Table 68. Global Dasatinib Drugs Revenue (Million US$) Market Share Forecast by Type (2021-2026) Table 69. Global Dasatinib Drugs Sales (K Units) Forecast by Application (2021-2026) Table 70. Global Dasatinib Drugs Revenue (Million US$) Forecast by Application (2021-2026) Table 71. Global Dasatinib Drugs Sales (K Units) Forecast by Region (2021-2026) Table 72. Global Dasatinib Drugs Sales Market Share Forecast by Region (2021-2026) Table 73. Global Dasatinib Drugs Revenue Forecast by Region (2021-2026) (US$ Million) Table 74. Global Dasatinib Drugs Revenue Market Share Forecast by Region (2021-2026) Table 75. Research Programs/Design for This Report Table 76. Key Data Information from Secondary Sources Table 77. Key Data Information from Primary Sources List of Figures Figure 1. Picture of Dasatinib Drugs Figure 2. Global Dasatinib Drugs Sales Market Share by Type: 2020 VS 2026 Figure 3. 20mg Product Picture Figure 4. 50mg Product Picture Figure 5. 70mg Product Picture Figure 6. Global Dasatinib Drugs Consumption Market Share by Application: 2020 VS 2026 Figure 7. CML Figure 8. ALL Figure 9. Global Dasatinib Drugs Market Size 2015-2026 (US$ Million) Figure 10. Global Dasatinib Drugs Sales Capacity (K Units) (2015-2026) Figure 11. Global Dasatinib Drugs Market Size Market Share by Region: 2020 Versus 2026 Figure 12. Dasatinib Drugs Sales Share by Manufacturers in 2020 Figure 13. Global Dasatinib Drugs Revenue Share by Manufacturers in 2019 Figure 14. The Global 5 and 10 Largest Players: Market Share by Dasatinib Drugs Revenue in 2019 Figure 15. Dasatinib Drugs Market Share by Company Type (Tier 1, Tier 2 and Tier 3): 2015 VS 2019 Figure 16. Global Dasatinib Drugs Sales Market Share by Region (2015-2020) Figure 17. Global Dasatinib Drugs Sales Market Share by Region in 2019 Figure 18. Global Dasatinib Drugs Revenue Market Share by Region (2015-2020) Figure 19. Global Dasatinib Drugs Revenue Market Share by Region in 2019 Figure 20. North America Dasatinib Drugs Sales Market Share by Country in 2019 Figure 21. North America Dasatinib Drugs Revenue Market Share by Country in 2019 Figure 22. U.S. Dasatinib Drugs Sales Growth Rate (2015-2020) (K Units) Figure 23. U.S. Dasatinib Drugs Revenue Growth Rate (2015-2020) (US$ Million) Figure 24. Canada Dasatinib Drugs Sales Growth Rate (2015-2020) (K Units) Figure 25. Canada Dasatinib Drugs Revenue Growth Rate (2015-2020) (US$ Million) Figure 26. Europe Dasatinib Drugs Sales Market Share by Country in 2019 Figure 27. Europe Dasatinib Drugs Revenue Market Share by Country in 2019 Figure 28. Germany Dasatinib Drugs Sales Growth Rate (2015-2020) (K Units) Figure 29. Germany Dasatinib Drugs Revenue Growth Rate (2015-2020) (US$ Million) Figure 30. France Dasatinib Drugs Sales Growth Rate (2015-2020) (K Units) Figure 31. France Dasatinib Drugs Revenue Growth Rate (2015-2020) (US$ Million) Figure 32. U.K. Dasatinib Drugs Sales Growth Rate (2015-2020) (K Units) Figure 33. U.K. Dasatinib Drugs Revenue Growth Rate (2015-2020) (US$ Million) Figure 34. Italy Dasatinib Drugs Sales Growth Rate (2015-2020) (K Units) Figure 35. Italy Dasatinib Drugs Revenue Growth Rate (2015-2020) (US$ Million) Figure 36. Russia Dasatinib Drugs Sales Growth Rate (2015-2020) (K Units) Figure 37. Russia Dasatinib Drugs Revenue Growth Rate (2015-2020) (US$ Million) Figure 38. Asia Pacific Dasatinib Drugs Sales Market Share by Region in 2019 Figure 39. Asia Pacific Dasatinib Drugs Revenue Market Share by Region in 2019 Figure 40. China Dasatinib Drugs Sales Growth Rate (2015-2020) (K Units) Figure 41. China Dasatinib Drugs Revenue Growth Rate (2015-2020) (US$ Million) Figure 42. Japan Dasatinib Drugs Sales Growth Rate (2015-2020) (K Units) Figure 43. Japan Dasatinib Drugs Revenue Growth Rate (2015-2020) (US$ Million) Figure 44. South Korea Dasatinib Drugs Sales Growth Rate (2015-2020) (K Units) Figure 45. South Korea Dasatinib Drugs Revenue Growth Rate (2015-2020) (US$ Million) Figure 46. India Dasatinib Drugs Sales Growth Rate (2015-2020) (K Units) Figure 47. India Dasatinib Drugs Revenue Growth Rate (2015-2020) (US$ Million) Figure 48. Australia Dasatinib Drugs Sales Growth Rate (2015-2020) (K Units) Figure 49. Australia Dasatinib Drugs Revenue Growth Rate (2015-2020) (US$ Million) Figure 50. Taiwan Dasatinib Drugs Sales Growth Rate (2015-2020) (K Units) Figure 51. Taiwan Dasatinib Drugs Revenue Growth Rate (2015-2020) (US$ Million) Figure 52. Indonesia Dasatinib Drugs Sales Growth Rate (2015-2020) (K Units) Figure 53. Indonesia Dasatinib Drugs Revenue Growth Rate (2015-2020) (US$ Million) Figure 54. Thailand Dasatinib Drugs Sales Growth Rate (2015-2020) (K Units) Figure 55. Thailand Dasatinib Drugs Revenue Growth Rate (2015-2020) (US$ Million) Figure 56. Malaysia Dasatinib Drugs Sales Growth Rate (2015-2020) (K Units) Figure 57. Malaysia Dasatinib Drugs Revenue Growth Rate (2015-2020) (US$ Million) Figure 58. Philippines Dasatinib Drugs Sales Growth Rate (2015-2020) (K Units) Figure 59. Philippines Dasatinib Drugs Revenue Growth Rate (2015-2020) (US$ Million) Figure 60. Vietnam Dasatinib Drugs Sales Growth Rate (2015-2020) (K Units) Figure 61. Vietnam Dasatinib Drugs Revenue Growth Rate (2015-2020) (US$ Million) Figure 62. Latin America Dasatinib Drugs Sales Market Share by Country in 2019 Figure 63. Latin America Dasatinib Drugs Revenue Market Share by Country in 2019 Figure 64. Mexico Dasatinib Drugs Sales Growth Rate (2015-2020) (K Units) Figure 65. Mexico Dasatinib Drugs Revenue Growth Rate (2015-2020) (US$ Million) Figure 66. Brazil Dasatinib Drugs Sales Growth Rate (2015-2020) (K Units) Figure 67. Brazil Dasatinib Drugs Revenue Growth Rate (2015-2020) (US$ Million) Figure 68. Argentina Dasatinib Drugs Sales Growth Rate (2015-2020) (K Units) Figure 69. Argentina Dasatinib Drugs Revenue Growth Rate (2015-2020) (US$ Million) Figure 70. Middle East and Africa Dasatinib Drugs Sales Market Share by Country in 2019 Figure 71. Middle East and Africa Dasatinib Drugs Revenue Market Share by Country in 2019 Figure 72. Turkey Dasatinib Drugs Sales Growth Rate (2015-2020) (K Units) Figure 73. Turkey Dasatinib Drugs Revenue Growth Rate (2015-2020) (US$ Million) Figure 74. Saudi Arabia Dasatinib Drugs Sales Growth Rate (2015-2020) (K Units) Figure 75. Saudi Arabia Dasatinib Drugs Revenue Growth Rate (2015-2020) (US$ Million) Figure 76. U.A.E Dasatinib Drugs Sales Growth Rate (2015-2020) (K Units) Figure 77. U.A.E Dasatinib Drugs Revenue Growth Rate (2015-2020) (US$ Million) Figure 78. Sales Market Share of Dasatinib Drugs by Type (2015-2020) Figure 79. Sales Market Share of Dasatinib Drugs by Type in 2019 Figure 80. Revenue Share of Dasatinib Drugs by Type (2015-2020) Figure 81. Revenue Market Share of Dasatinib Drugs by Type in 2019 Figure 82. Global Dasatinib Drugs Sales Growth by Type (2015-2020) (K Units) Figure 83. Global Dasatinib Drugs Sales Market Share by Application (2015-2020) Figure 84. Global Dasatinib Drugs Sales Market Share by Application in 2019 Figure 85. Global Revenue Share of Dasatinib Drugs by Application (2015-2020) Figure 86. Global Revenue Share of Dasatinib Drugs by Application in 2020 Figure 87. Bristol-Myers Squibb Total Revenue (US$ Million): 2019 Compared with 2018 Figure 88. LUCIUS Pharma Total Revenue (US$ Million): 2019 Compared with 2018 Figure 89. Price Trend of Key Raw Materials Figure 90. Manufacturing Cost Structure of Dasatinib Drugs Figure 91. Manufacturing Process Analysis of Dasatinib Drugs Figure 92. Dasatinib Drugs Industrial Chain Analysis Figure 93. Channels of Distribution Figure 94. Distributors Profiles Figure 95. Porter's Five Forces Analysis Figure 96. North America Dasatinib Drugs Sales (K Units) and Growth Rate Forecast (2021-2026) Figure 97. North America Dasatinib Drugs Revenue (Million US$) and Growth Rate Forecast (2021-2026) Figure 98. Europe Dasatinib Drugs Sales (K Units) and Growth Rate Forecast (2021-2026) Figure 99. Europe Dasatinib Drugs Revenue (Million US$) and Growth Rate Forecast (2021-2026) Figure 100. Latin America Dasatinib Drugs Sales (K Units) and Growth Rate Forecast (2021-2026) Figure 101. Latin America Dasatinib Drugs Revenue (Million US$) and Growth Rate Forecast (2021-2026) Figure 102. Middle East and Africa Dasatinib Drugs Sales (K Units) and Growth Rate Forecast (2021-2026) Figure 103. Middle East and Africa Dasatinib Drugs Revenue (Million US$) and Growth Rate Forecast (2021-2026) Figure 104. Asia Pacific Dasatinib Drugs Sales (K Units) and Growth Rate Forecast (2021-2026) Figure 105. Asia Pacific Dasatinib Drugs Revenue (Million US$) and Growth Rate Forecast (2021-2026) Figure 106. Bottom-up and Top-down Approaches for This Report Figure 107. Data Triangulation Figure 108. Key Executives Interviewed

Bristol-Myers Squibb LUCIUS Pharma